Docosahexaenoic Acid (DHA) for Reducing Aortic Systolic Blood Pressure
ChangeBridge: EPO Bulletin - Therapeutics (A61P)
Summary
The European Patent Office published patent EP4009965A1, granted to Swinburne University of Technology (Australia), covering the use of Docosahexaenoic Acid (DHA) for acutely reducing aortic systolic blood pressure. Inventors are Andrew Pipingas and Andrew Scholey. The patent is designated across 36 European states including DE, FR, GB, IT, ES, NL, and others.
What changed
The EPO granted patent EP4009965A1 for pharmaceutical compositions containing DHA (IPC A61K 31/202) for therapeutic use in reducing aortic systolic blood pressure. The patent covers multiple formulation types including fish oil (A61K 35/60) and plant-derived sources (A61K 36/28, A61K 36/52). Additional claims address neurological applications (A61P 25/28) and cardiovascular indications (A61P 9/00, A61P 9/12).
Patent holders and licensees should review the claims to assess freedom-to-operate for competing DHA-based blood pressure products in designated states. The patent provides 20-year exclusivity from filing date (2020) in designated contracting states. Companies developing similar omega-3 fatty acid formulations for cardiovascular indications should conduct freedom-to-operate analyses.
Source document (simplified)
DOCOSAHEXAENOIC ACID (DHA) FOR ACUTELY REDUCING AORTIC SYSTOLIC BLOOD PRESSURE
Publication EP4009965A1 Kind: A1 Mar 25, 2026
Applicants
Swinburne University of Technology
Inventors
PIPINGAS, Andrew, SCHOLEY, Andrew
IPC Classifications
A61K 31/202 20060101AFI20231012BHEP A61P 9/00 20060101ALI20231012BHEP A61P 25/28 20060101ALI20231012BHEP A61K 35/60 20060101ALI20231012BHEP A61K 36/28 20060101ALI20231012BHEP A61K 36/52 20060101ALI20231012BHEP A23L 33/12 20160101ALI20231012BHEP A61P 9/12 20060101ALI20231012BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.